chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The vaccine was administered without being diluted. The vaccination was at 4:50pm. At the time of the vaccination the patient cried a little bit before receiving the vaccine and for a minute or so after. She said that her arm hurt. The error was discovered in the evening when documenting wasted doses.  I spoke with the patient's mother at 9:30pm and at that time she did not report any additional side effects to me.  I spoke with her again at 8:30am this morning and she said her daughter did not "feel well" and was tired.
Vaccine vial was stored in the refrigerator for more than 30 days; administered expired Moderna Covid-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine vial was stored in the refrigerator for more than 30 days) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired Moderna Covid-19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine vial was stored in the refrigerator for more than 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered expired Moderna Covid-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine vial was stored in the refrigerator for more than 30 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   The vial was initially stored in the refrigerator on 16-Dec-2021. The vial did not undergo temperature excursion.   No treatment details were reported.
About 5 weeks ago, first time I tested positive for COVID-19. I came down with covid symptoms on 03/21/2023. I initially tested negative on 03/22/2023 in the morning.  I had body aches, mild, and fatigue. I had no respiratory symptoms, no cough or congestion.  I tested positive on 03/23/2023. My symptoms lasted for a couple of days. I isolated for my symptoms for ten days.  I did contact my doctor office and she wrote a prescription for Paxlovid medication for me but I decided not to take it.
Tingling, weakness, and burning sensation on arms, hands, feet, legs, and back. Peripheral neuropathy.  Nausea, headache, heart palpitations, lightheadedness, fatigue, stiff neck, indigestion
Patient had previously been giving Moderna dose #1 without issue. Dose #2 was injected, within one minute, patient reported difficulty breathing and face was incredibly red. Pharmacist Administered one dose of Epinephrine 0.3mg and called 911. Within one minute after epinephrine administration, patient had breathing issues resolved and face went back to normal. A second dose of Epinephrine was not needed. Paramedics arrived, evaluated, and took to hospital for further monitoring. No further reports of outcomes.
Fever to 102, severe body aches, nausea and headache for 48 hours  Responded well to Tylenol
Got Td on 03/28/05 on 03/29/05 left arm, warm, pain, swelling, large red rash below injections site. Fever, paresthesia, injection at injection site. Rx. with Keflex briefly then stopped and Claritin and one short course of edema and problem fully persisted.
allergic to mercury; adverse event NOS; Initial information received on 04-Oct-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a female patient (age unknown) who experienced allergic to mercury (allergy to metals) and adverse event nos (adverse event), while she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient experienced a non-serious allergic to mercury (allergy to metals) and adverse event nos (adverse event) (Unknown latency) following the administration of INFLUENZA VACCINE.  (Other relevant tests included no lab data.)  Final diagnosis was adverse event nos and allergic to mercury.  It was not reported if the patient received a corrective treatment.  The patient outcome was not reported for allergic to mercury and adverse event nos.  Information on the batch number was requested.  List of documents held by sender: none.
On the evening of the vaccine the headache started and arm was sore. But 9 out of the last 12 days I've had headaches and I don't normally have headaches.
Could not use Left Hand; numbness to their left arm and hand, and their left foot.; Heart Palpitations; Feel Sick; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Could not use Left Hand) and HYPOAESTHESIA (numbness to their left arm and hand, and their left foot.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Penicillin allergy and Mitral valve prolapse (Heart) since 1993. Concomitant products included CARVEDILOL, LOSARTAN POTASSIUM and ALPRAZOLAM (XANAX) for an unknown indication.    On 02-Jun-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Jun-2021, the patient experienced HYPOAESTHESIA (numbness to their left arm and hand, and their left foot.) (seriousness criterion hospitalization) and ILLNESS (Feel Sick). On 07-Jun-2021, the patient experienced PALPITATIONS (Heart Palpitations). On an unknown date, the patient experienced LIMB DISCOMFORT (Could not use Left Hand) (seriousness criterion hospitalization). On 10-Jun-2021, PALPITATIONS (Heart Palpitations) had resolved. At the time of the report, LIMB DISCOMFORT (Could not use Left Hand) had not resolved and HYPOAESTHESIA (numbness to their left arm and hand, and their left foot.) and ILLNESS (Feel Sick) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2021, Magnetic resonance imaging: unknown Inconclusive. On an unknown date, Chest scan: unknown Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: the follow up document received contains no significant information(NNI).; Reporter's Comments: Patient took water pills as treatment medication. On day 5 the patient felt sick on 02 Jun 2021, she went to emergency room with her chest hunting and left side numbness of the body. She also had Magnetic resonance imaging (MRI) and shown to several doctors. Then went to post-exposure prophylaxis (PEP)on 10 Jun 2021. On 10 Jun 2021 she took off work on medical leave for a week. She could not able to use her left hand good and still waiting to see neurologist. The patient had not ever tested positive for COVID-19, and had not taken any prescriptions, over the counter medication, dietary supplement or herbal remedies at the time of vaccination. The patient had not experienced similar adverse event in the past and other potential causes for the event was unknown.
Swollen, red arm with mild scabbing with an amber crust. Swelling from shoulder to elbow, warmer to touch than other skin. OMNICEF orally started for possible infection. Left arm only affected.
Patient admitted for previously scheduled surgery.  His wife was incidentally detected for COVID at home and he was tested which resulted as "detected."  Admission was for surgery - not r/t COVID.
Pt had flu in L arm-mild redness. Pt had PNEUMOVX in R arm-red, warm, swollen area about 5" x 5" round with pain with movement.
Pruritus followed by redness and localized induration (20mm) at injection site, 2 days after vaccination. Note: No reaction with 1st dose.
pt recv vax 8SEP97 11AM & not ill @ that time;left clinic w/mom out shopping by 3PM @ home t102.4 & stuffy nose;has never had adverse event;PHN advised mom to call PMD;
16 yo patient came with dad to get booster. nurse was helping administer covid vaccines and thought 16yo could mix and match boosters as well. dad asked to switch if ok to do so and nurse said ok. Moderna not yet approved for those under 18 yo. dad notified of error.
Staff member presents with complaints of fatigue, shortness of breath, sweating, joint pain and pain at injection site.
Fever, chills, flu-like symptoms, fatigue, nausea, headache-began 12hrs after vaccine
Severe pain in both arms starting at the point of injection down to my hands, lasting from 1 hour to 4 or 5 hous.  My doctor said it could not be from the injection and blew me off.  I never know when the pain will start or stop.  But so far it has happened about twice a month and seems to be getting worse. And now I am also getting weak and my blood sugar in the morning is between 80 and 110.  When it used to be about 100, with NO medication.
Injection site pain, swelling, hot. Tingling lips and feet.  Increased heart rate (up avg 40-50 bpm for 24 hrs. Fever up to 102F. Headache,  body/joints ached. Dizzy/light headed.
Information has been received from a nurse referring to a patient of unknown age and gender. There was no information about the patient's medical history and concurrent condition. On 15-OCT-2015 the patient was vaccinated with a dose of improperly stored VARIVAX (lot # L019125, expiration date: 27-MAY-2017, dose and route unknown). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Severe muscle and joint pain. Severe migraines- headache. Chills and heavy sweating. Body shakes. Fever two nights in a row. Exhaustion. Indegestion and lack of appetite. Trouble walking and moving around- pain in legs and feet. Sore left arm.
53 year old female complained of headache, had hives and redness on neck and chest, and numbness and tingling on her lip and throat. 1745 Blood pressure at 191/98, patient given Benadryl 50 mg IM to left deltoid. 1753 Blood pressure 206/109 and pulse 93, per unit manager hold epi pen due to high blood pressure. Called 911 services due to high blood pressure at 1800 blood pressure 224/118. Patient taken to ER via ambulance.
Severe 10/10 crushing and aching pain to maxilla and mandible areas. Distressing pain.; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 29Oct2022 at 20:15 as dose 4 (booster), single (Lot number: GH9697) at the age of 56 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MIRALAX; COLACE; CLONOPIN; MAGNESSIUM CARBONATE; BEANO. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; manufacturer unknown), for Covid-19 Immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); manufacturer unknown), for Covid-19 Immunization. The following information was reported: PAIN IN JAW (non-serious) with onset 30Oct2022 at 23:45, outcome "recovered", described as "Severe 10/10 crushing and aching pain to maxilla and mandible areas. Distressing pain.". Therapeutic measures were taken as a result of pain in jaw.
given vaccine which was beyond the 30 day use by date; No adverse event; given vaccine which was beyond the 30 day use by date; given vaccine which underwent temperture excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (given vaccine which underwent temperture excursion), EXPIRED PRODUCT ADMINISTERED (given vaccine which was beyond the 30 day use by date), PRODUCT STORAGE ERROR (given vaccine which was beyond the 30 day use by date) and NO ADVERSE EVENT (No adverse event) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 083B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Sep-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. In August 2022, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (given vaccine which underwent temperture excursion). On 19-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (given vaccine which was beyond the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (given vaccine which was beyond the 30 day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (given vaccine which underwent temperture excursion), EXPIRED PRODUCT ADMINISTERED (given vaccine which was beyond the 30 day use by date), PRODUCT STORAGE ERROR (given vaccine which was beyond the 30 day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (given vaccine which underwent temperture excursion), EXPIRED PRODUCT ADMINISTERED (given vaccine which was beyond the 30 day use by date) and PRODUCT STORAGE ERROR (given vaccine which was beyond the 30 day use by date).    No relevant concomitant medications were reported.  Patient had gotten vaccine which underwent temperature excursion on 15-17Aug 2022.  No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-681465, US-MODERNATX, INC.-MOD-2022-682168 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-681465: US-MODERNATX, INC.-MOD-2022-682168:
This spontaneous report was received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. Pertinent medical history, concurrent conditions and concomitant therapies were not reported. On an unknown dates, the patients were vaccinated with doses of RECOMBIVAX (lot number and expiration dates not reported) for prophylaxis, which were improperly stored at >46°F but < 77°F for 15 minutes. No adverse effects were reported. There were no previous temperature excursions and call was done because of a data logger. No further information was provided. This is one of 5 reports from the same source. Additional information has been requested. Sender's Comments: US-009507513-1701USA009556: US-009507513-1701USA009569: US-009507513-1701USA009570: US-009507513-1701USA009572.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021 at 11:56 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021 at 11:56 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 16-Sep-2021 at 11:56 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Treatment information was not provided.
Patient was given the vaccine about 1:30 pm on 10/17/18 and she said that evening of the same day her arm began to swell around the site of the injection and become hot or warm and hurt.  The patient applied cold packs and the swelling moved down her arm and into her back. On 10/19/18 the patient called the pharmacy and came by. I called her doctor and recommended that she go to the doctor for a visit. The doctor prescribed prednisone and doxycycline for the patient.
The pt developed wheezes and crackles in lungs. There was a large warm and edematous area on her left deltoid about 3". She complained of a headache. She was treated with Benadryl 50mg, IM, and Alupent 0.3cc in NS 3cc RT treatment was given.
Patient reported bumps on the roof of her mouth and itching- treated with benadryl 50 mg PO
No adverse effect reported; patient was inadvertently administered a dose of RECOMBIVAX and ROTATEQ/ Temperature: 47.5F; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions, allergies and concomitant medications were not reported.   On 30-JUL-2019, the patient was inadvertently administered a dose of Hepatitis B vaccine (recombinant) thimerosal-free (RECOMBIVAX HB) (schedule, dose number, route and anatomical location of vaccination not provided; lot # R031052, expiration date: 03-JUN-2021) and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (schedule and dose number not provided; lot #R029815, expiration date: 18-JUN-2020) both indicated as prophylaxis, that had been improperly stored (product storage error) at a temperature of 47.5 degrees Fahrenheit (°F) for a time frame of 2 hours and 45 minutes, as detected by a digital data logger. There was not a previous temperature excursion. No adverse effect reported.
Information has been received from a nurse practitioner concerning a male child who in July 1995 was vaccinated with a dose of varicella vaccine. On 09/13/2001, the child presented to the physician's office with a temp of 101 deg F and 2-4 vesicles on his face and one on his chest. It was reported that macular eruptions were present in different stages in his stomach, back and legs. Within 24 hrs, the child developed a more perfuse breakout which dried up very quuickly and he has since returned to school. Additional info has been requested.
A report was received from a health care professional on 08Nov02, concerning a female vaccinee who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC. No adverse reaction was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment. Cross reference with: PJP-2002-00731, PJP200200729, PJP200200749, PJP200200744, PJP200200742, PJP200200720, PJP200200745, PJP200200690, PJP200200743.
10/6/98 pt recv vax, on 11/13/98 devel a ``blotchy, erythematous, papular rash w/a typical measles appearance on the stomach & torso.
Information has been received from a licensed practical nurse concerning an 11 year old male with down's syndrome, cardiac disorder, amoxicillin allergy, Suprax drug allergy and a Extendryl drug allergy. On 02/03/1997 the pt was vaccinated with varicella vaccine SC in the right arm. On 03/19/2001 the pt experienced chicken pox. Subsequently, the pt recovered from chicken pox. Additional info is not expected.
Tachycardia at rest and on exertion. HR 15-20 faster than baseline
severe burning at shot sight - pain and tenderness to touch. Headaches continuous - nausea and occasional vomiting body aches and fever that ran approx 2- days.
Pain at Injection Site-Medium, Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Hypotension-Severe, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Severe, Additional Details: recieved shot at 3:10pm, patient reported severe arm pain, nausea, blurred vision. 1st bp: 96/66 pulse 64 at 3:34pm, 2nd bp:102/68 pulse 62 at 3:50pm, 3rd bp 122/76 pulse 68 at 4:04pm. advised pt not to drive  and left pharmacy around 4:10pm, observed patient for over 30mins due to use of epipen for cipr allergy in past
Left arm sore, and numb feeling, lymph nodes under left are swollen and very painful, general tiredness and body aches.
Vial administered was stored outside recommended temperature. First puncture was 6/23 @ 256p.  Pt only complained of sore arm at injection site
Information has been received from a physician concerning a female who was vaccinated with a 0.65 ml dose of ZOSTAVAX. it was reported that the patient developed a chickenpox like rash. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
patient was in his usual state of health with multiple chronic medical conditions when the flu vaccine was administered on Friday 10/8. On Tuesday 10/12 the foster home called to report that the patient was found deceased on the floor. Appears to have died suddenly.  There is no way to know if there was a causal relation but felt it was important to report due to timing of death shortly after vaccination.
Severe Headache; Severe Chest Pain; head and nose congestion; head and nose congestion; body aches; arm pain; This is a spontaneous report from a contactable consumer (patient). A 65-year-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection Lot Number: EW0187), via an unspecified route of administration, administered in Arm Right on 25Jun2021 14:30 as dose 1, single for COVID-19 immunization. Patient medical history included asthma, Afib (atrial fibrillation), HTN, cholesterol, overweight and patient had known allergies. The concomitant medications were not reported. It was stated that, she did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She had received other medications within 2 weeks of vaccination. She was not diagnosed with COVID-19, prior to vaccination and tested for COVID-19 since the vaccination. On 26Jun2021 02:30, the patient experienced severe headache, severe chest pain, head and nose congestion, body aches and arm pain. Patient did not receive any treatment for the events. The seriousness of the event was considered as non-serious. The outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
#033C21A - 55 recipients identified-vaccine was stored in the refrigerator beyond-use-date of 30 days and provider continued to administer; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (#033C21A - 55 recipients identified-vaccine was stored in the refrigerator beyond-use-date of 30 days and provider continued to administer) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (#033C21A - 55 recipients identified-vaccine was stored in the refrigerator beyond-use-date of 30 days and provider continued to administer). At the time of the report, EXPIRED PRODUCT ADMINISTERED (#033C21A - 55 recipients identified-vaccine was stored in the refrigerator beyond-use-date of 30 days and provider continued to administer) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter No treatment information was provided by the reporter
Dizzy episode after 1st GARDASIL 8/18/08. Dizzy episode after 2nd GARDASIL 10/22/08. See attached.